The phenomenon is likely caused by the unique chromatin architecture surrounding the SOX2 gene: (1) glioma- and squamous cancer-specific enhancers are distributed in two adjacent insulated neighborhoods demarcated by CTCF binding; (2) SOX2 resides right at the boundary of the two neighborhoods so that it has access to both. Here, SOX2 is linked to glioma.